[通过对精神刺激剂有反应的分子调节认知和精神功能]
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama.
概括
甲基胺影响大脑的奖励通路,影响认知和精神功能. 像Shati/Nat8l和Piccolo这样的分子是这些甲基胺诱导的大脑变化的关键参与者,也是治疗疾病的潜在目标.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲基胺 (精神兴奋剂) 影响大脑的奖励系统 (腹部体区域到体核).
- 甲基胺使用导致依赖,幻觉,妄想和认知功能障碍.
- 响应甲基胺的分子对于理解大脑功能和疾病至关重要.
研究的目的:
- 审查Shati/Nat8l和Piccolo的功能,这些分子对甲基胺有反应.
- 基于动物研究,探索它们在认知和精神功能中的作用.
- 突出其作为大脑疾病研究目标的潜力.
主要方法:
- 关于对甲基胺反应分子的动物研究的综述.
- 对Shati/Nat8l在突触功能,成和阿尔茨海默病病理学的作用的分析.
- 检查皮科洛对甲基胺诱导的行为和精神分裂症样变化的贡献.
主要成果:
- 沙蒂/Nat8l与药物成,抑郁症和海马突触功能有关,上调可能会减轻阿尔茨海默氏症的认知缺陷.
- 核中Piccolo accumbens影响甲基胺诱导的行为改变.
- 前额叶皮层的皮科罗下调导致小鼠的精神分裂症样行为和神经元变化.
结论:
- 沙蒂和皮科洛对大脑功能至关重要,特别是在认知和精神病领域.
- 这些分子代表了研究和治疗大脑疾病的有希望的目标.
- 研究对甲基胺反应的分子对于我们进一步了解大脑功能至关重要.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
152
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
152
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
92
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
92
CNS Stimulants: Psychedelic Agents
116
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
116
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Drugs Affecting Neurotransmitter Release or Uptake
918
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
918
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


